Volitionrx (VNRX) Change in Accured Expenses (2019 - 2025)
Volitionrx's Change in Accured Expenses history spans 9 years, with the latest figure at -$726215.0 for Q4 2025.
- For Q4 2025, Change in Accured Expenses rose 9.29% year-over-year to -$726215.0; the TTM value through Dec 2025 reached $77977.0, up 106.41%, while the annual FY2025 figure was $77977.0, 106.41% up from the prior year.
- Change in Accured Expenses reached -$726215.0 in Q4 2025 per VNRX's latest filing, down from $993076.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q4 2023 to a low of -$949636.0 in Q3 2023.
- Average Change in Accured Expenses over 5 years is $57826.9, with a median of -$14238.5 recorded in 2022.
- Peak YoY movement for Change in Accured Expenses: tumbled 643.52% in 2021, then soared 36151.57% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $549403.0 in 2021, then crashed by 99.39% to $3345.0 in 2022, then skyrocketed by 36151.57% to $1.2 million in 2023, then tumbled by 166.02% to -$800624.0 in 2024, then grew by 9.29% to -$726215.0 in 2025.
- Per Business Quant, the three most recent readings for VNRX's Change in Accured Expenses are -$726215.0 (Q4 2025), $993076.0 (Q3 2025), and -$560926.0 (Q2 2025).